McCullough on Omicron and Treatment

Dr. Peter McCullough: "What we know so far is that it’s the most heavily mutated version of SARS-CoV-2. It has about 30 mutations in the spike protein. Ten in the receptor binding domain and the S1 segment. These mutations have jumped much more forward compared to Delta, which was about seven mutations in the spike protein. And according to the first attempts at modeling, this virus will have a lower infectivity than the Delta variant. . . .

“Many have advised, and I did as well, that it would be a blunder to try and do a mass vaccination in the middle of a global pandemic. . . .

“The virus in a sense multiplies in the nose to a great extent before it enters the body . . . We have oral nasal decontaminant strategies now . . . There’s a lot of innovation on a local level. . . .

“The virus is actually carried and spread in the NOSE. It’s not a hand infection. Hand sanitizer was a completely useless endeavor . . .

“Treating the virus in the nose and mouth is where the action is.”